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Effects of Berberine, Chelerythrine, and Sanguinarine on Proliferation
in Four Human Immortalized Cell Lines
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Bloodroot (Sanguinaria canadensis L., Papaveraceae) is a plane rich in benzophenanchridine (isoquinoline) alkaloids ~uch_ as
sanguinarine and chelerychrine. Boch isolated alkaloids and whole-tissue rhizome extracts ha:'e demo.nscr:iced zn ~ttro
anticarcinogenic (antiproliferacive) activity in limited immortalized cell culture models, but the relauve contnbuc1on of vanous
alkaloid constituents ro whole-tissue extract activity, and whether or not various alkaloids may ace synergiscically, has not been
investigated. We challenged four immortalized cell lines (Jurkat, K562, Ramos, U937) with various doses of .chelerythr!ne,
sanguinarine, and berberine (a structurally and functionally similar alkaloid absent from bloodroot), alone and m al\ ~ss1b\e
combinations, and measured proliferation rates 48 hours pose-treatment. K562 cells were unaffected by all doses of berberme and
chelerychrine tested, but showed antiproliferative activity at 0. 5 µg/mL sangui?arine. Th.e doses. of sanguinarine necessary. to
elicit anti-proliferative effects in these experiments matched well with chose seen m whole-Cissue rhizome extracts demonscracmg
similar anti-proliferative effects. When a 2 µg/mL dose of sanguinarine was tested in all four cell lines, sanguinarine elicited even
stronger antiproliferacive effects in Jurkat, Ramos, and U937 cells compared to K562 cells; these three cell lines also
demonstrated reduced proliferation in the presence of chelerythrine at a dose of 1 µg/mL whereas K562 did not. Ac the doses
tested here, berberine had no direct effect on proliferation. These results suggest chat sanguinarine may be responsible for the
bulk of anticarcinogenic activity from bloodroot whole-tissue rhizome extracts, but that ocher alkaloids such as chelerythrine
may also play important roles contingent on cell type.

INTRODUCTION
Bloodroot (Sanguinaria canadensis L.) is an herbaceous perennial
found in eastern and central North America (Graf et al., 2007;
Figure 1). Botanically, it is the only member of the genus
Sanguinaria. This genus belongs to the poppy family (Papaveraceae) which is well-known for its medicinal compounds. The
Native American tradition of using bloodroot as a medicinal
plant has changed but continued into the twenty-first century
where it has had two primary indications: as a dental care agent
(Hong et al. 2005) and an anti-skin cancer agent (Moran and
Helm 2008; DeStefano et al. 2009; Wang and Warshaw 2012).
More recent research suggests it may be anticarcinogenic against
other non-dermal cells types, such as breast, intestinal, and
lymphatic cancer cells (Han et al. 2008; Kim et al. 2008; Choi
et al. 2009a; Mazzio and Soliman 2009; Lee et al. 2012).
The purported primary bioaccive molecule from bloodroot
is sanguinarine, a benzophenanthridine (isoquinoline) alkaloid
which is the most prevalent alkaloid in bloodroot extracts
(Campbell et al. 2007; De Stefano et al. 2009). It is also found in
ocher members of Papaveraceae as well as the fumitory family
(Fumariaceae), the buttercup family (Ranunculaceae), and the
citrus family (Rutaceae) (Vecera et al. 2007). Most research has
focused on the activity of chis lone molecule in in vitro cell culture
models (Choi et al. 2009b; Mishra et al. 2009; Vrba et al. 2009)
where it has conclusively shown anticarcinogenic effects that
appear to be specific towards cancerous cells and not healthy cells
(Ahmad et al. 2000). Our team has shown similar activity by
*Author for correspondence (DSS): Olin Hall 415, 2507 University
Ave., Drake University, Des Moines, IA 50311, Tel. 1 515 271 2956,
Fax 1 515 271 3702, dssenchina@drake.edu

whole-tissue extracts from bloodroot rhizomes, in which sanguinarine
was the most abundant alkaloid; in our model, those extracts reduced
proliferation of the human myelogenous leukemia cell line K562
while stimulating proliferation of peripheral blood mononuclear cells
from healthy young human adults (Senchina et al. 2009a). However,
formal analyses of the proliferation data (and accompanying cycokine
secretion data) from that and other srudies (Senchina et al. 2009b;
Senchina et al. 2012) collectively suggest that sanguinarine content
alone may not account for all observed immunoodulatory effects.
Whether or not other alkaloids present in the plant (or other
scrucrurally-similar compounds found in other plant genera) may
contribute to such effects is unknown. Chelerythrine is one such
candidate alkaloid also found in bloodroot (Graf et al. 2007), other
members of Papaeveraceae, and two other families (Fumariaceae and
Rutaceae; Zdarilova et al. 2006). Chelerythrine demonstrates similar
anti-cancer properties as sanguinarine (Vogler et al. 2009; Hammerova et al. 2011). Whether alkaloids such as chelerychrine and
sanguinarine may interact in a synergistic or combinatorial manner
has not been directly demonstrated; however, Larsson et al. (2009)
showed chat sanguinarine weakly synergizes with other chemotherapeutic drugs in vitro.
As an attempt to "bridge the gap" between those studies that
examined cell proliferation or apoptosis utilizing alkaloid-rich
bloodroot extracts and chose using sanguinarine alone, a series of
experiments were undertaken. The anti-proliferative activity of
both sanguinarine and chelerythrine were investigated, as well as
a structurally-similar third alkaloid (berberine) which is not
present in bloodroot but is found in ocher closely related plant
families. Four immortalized cell lines representative of the human
immune system (Jurkat, K562, Ramos, U937) were tested
against the three alkaloids. The aim of the first experiment was to
determine if the three alkaloids had similar or different effects on
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Fig. 1.
Bloodroot (Sanguinaria canadensis L) from Carr Woods in Ames, Iowa, spring 2013. Left: Plant in anthesis with newly-emerged
leaves clasping the petiole, approximately 9 cm tall (April}. Right: Plant fruiting (see leaf center) with more mature leaves, after a late
snowstorm (May).
K562 cell proliferation at various doses including those found m

whole-tissue rhizome extracts; an ancillary aim of rhe first
experiment was to determine if the alkaloids acted synergistically.
The aim of the second experiment was to determine if other cell
lines responded similarly to K562 cells under the same treatment
doses. For both experimental series, cells were cultured with each
alkaloid, alone or in all possible combinations, for 48 hours after
which time cells were counted and compared to baseline.
METHODS
K562 cells (representing undifferentiated granulocytes) were
generously provided by Dr. Joan E. Cunnick (Iowa State
University). Jurkat E6-l (representing T cells), Ramos RAl
(representing B cells), and U93 7 (representing monocytes) cell
lines were purchased from ATCC. All four cell lines are nonadherent in culture. The culture media was CRPMI, based on a
recipe of 440 mL RPMI (GIBCO) supplemented with HJ mL of
penicillin/streptomycin (GIBCO) and 50 mL fetal bovine serum
(Mediatech). Berberine, chelerythrine, and sanguinarine (Figure 2;
obtained from Sigma-Aldrich) were diluted into stock concentrations (see below), stored at -80°C, and tested within two months
of preparation. Some of these compounds are photosensitive and
require being kept in dark conditions; however, aqueous solutions
of dilutions stored at --80°C are biochemically srable and maintain
immunomodulatory activity with long-term light-protected
storage at -80°C (Senchina et al. 2009b).
Cell cultures were grown for each of the four cell lines such
that approximately 150 mL of cell culture at 1.0 X l 0 5 cells/mt
was established prior to testing. For the experiments, cells were

partitioned as 5 mL cultures, with three flasks established for each
of eight different treatment conditions: (1) control (media alone),
(2) berberine
(3) chelerythrine alone,
sanguinarine alone,
(5) bcrberine + chelerythrine, (6) berberine + sanguinarine, (7)
chelerythrine + sanguinarine, (8) and all thee alkaloids together.
The initial concentrations of sanguinarine and chelerythrine for
stock solutions were chosen based on average concentrations found
in several batches of rhizome extracts, including those identified
previously (Senchina et al. 2009a) and additional rhizome extracts
currently under experimentation: sanguinarine at 0.8 ~tg/mL and
chelerythrine at OA µg/mL For berberine, we arbitrarily chose
to test it at the same concentration as chelerythrine. Final
concentrations of each alkaloid in the wells at the 1 X concentration
were as follows: 0.01 µg/mL for both berberine and chelerythrine,
and 0.02 µg/mL for sanguinarine. Cells were variously treated with
lX, lOX, or 100X doses. Cultures were grown under standard
incubation conditions
5% cob humidified) for 48 hours.
After incubation, number and viability of celis post-treatment
were assessed manually using a hemacytometer and Trypan blue
staining. Results were averaged across the three replicates for ail
eight conditions.
One-way ANOVA was used to check for significant differences in
proliferation across treatment conditions (PAS\l(! 17 .0, SPSS Inc.);
when a main effecr of treatment was uncovered, significance between
pairwise comparisons was determined
using LSD. Significance was defined as ::x<0,05 whereas a trend towards significance
was defined as O.Cl5<-:x<OJ. When multiple comparisons were
used within an ANOVA, a correction was made by dividing the
starting et-value of 0.05
the number of comparisons and
redefining significance based on the corrected p-value.
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Fig. 2.
Benzophenanthridine alkaloids used in this study.
According to Chaturvedi et al. 0997), all three are considered
chemical analogues of each other, and chelerythrine and sanguinarine are considered structural homologues. Sanguinarine and
chelerythrine are produced by bloodroot whereas berberine is not.
Structures were drawn using ChemSketch (ACD/Labs).
RESULTS
To determine the concentration of alkaloids necessary to
influence cell proliferation, initially only the K562 cells were
tested at 1 X (representing those found in rhizome ethanol
extracts based on Senchina et al. [2009a}), 10 X, and 100 X
concentrations (Table 1). There was a main effect of treatment
(p<0.001). Across all doses tested, only sanguinarine was able to

significantly diminish cell proliferation as compared to control, and
only at the lOOX concentration (2.0 µg/mL). This effect was
significant when sanguinarine was used alone or in combination with
one or both other alkaloids (p<0.001 all cases). There was also a
trend for the combination of berberine and chelerythrine to diminish
proliferation at lOOX concentrations (1.0 µg/mL each; p=0.001).
To better understand the dose-response relationship between
sanguinarine and K562 proliferation, sanguinarine alone was
tested at 25X, SOX, 75X, and lOOX concentrations (Figure 3).
There was a main effect of treatment (p<0.001) such that
proliferation was significantly lower at all treatment doses
compared to the vehicle control (all p<0.001), with the 25X
dose being 0.5 µg/mL. The collective data demonstrated the
expected dose-response relationship (e.g., average proliferation
values decreased as the concentration of sanguinarine increased).
However, there were no significant differences when the various
treatments were compared against each other.
To determine if other cell lines responded to the three
alkaloids similarly to how K562 cells had, cultures of Jurkat,
Ramos, and U937 cells were tested in the same manner using
only the lOOX alkaloid concentrations. Although all the results
from all three cell lines are presented together in Table 2,
separate ANOVA were run for each cell type independently of
others. There was a main effect of treatment for all three cell lines
(all p<0.001); p-values presented in the remainder of this
paragraph reference comparisons to control. Berberine alone had
no effect on cell proliferation in any of the three cell lines.
Chelerythrine alone or combined with berberine diminished cell
proliferation in all three cell lines (p::;0.003). Sanguinarine alone
caused complete cell culture death in all three cell lines
(p::;Q.001). Interestingly, the effects of sanguinarine on proliferation were sometimes different when sanguinarine was used in
combination with other alkaloids, and this phenomenon varied
by cell type. In the case of Jurkat and U937 cells, sanguinarine
combined with one or both other alkaloids either resulted in
complete cell culture death or cell culture stasis (p::;0.001). The
results with Ramos cells were more complex. Compared to
control, the proliferative response of Ramos cells was significantly
lower when sanguinarine was administered with one or both
other alkaloids (p<0.001). However, administration of sanguinarine in combination with one or both other alkaloids did not
result in complete cell culture death, as was the case when
sanguinarine was administered alone.

Table 1.
Proliferative response of K562 cells to three alkaloids at lX, lOX, and lOOX concentrations (starting
concentrations of 0.4 µg/mL for berberine and chelerythrine, and 0.8 µg/mL for sanguinarine). Each experiment was
performed in triplicate. Values are cell counts (expressed as 1.0 X 10 5 cells/mL) ± standard error. Asterisks (*) indicate
statistically significant differences of treatment compared to control within the same column (all p<0.001).
Relative Concentration
IX
Control
Berberine
Chelerythrine
Sanguinarine
Berberine + Chelerythrine
Berberine + Sanguinarine
Chelerythrine + Sanguinarine
All 3 Alkaloids

14.9
14.9
17.0
14.4
14.8
13.9
15.0
11.2

+
+
+
+
+
+

1.0
1.2
0.9
1.5
0.3
0.8
± 0.9
+ 0.8

lOX
14.9
13.4
18.1
15.8
15.4
12.7
15.5
11.7

+
+
+
+
+
+
+
+

IOOX
1.0
1.5
2.4
3.5
0.5
0.2
0.7

1.3

14.9
16.6
16.0
1.8
14.5
3.4
2.4
3.6

+
+
+
+
+
+
+

1.0
0.8
1.1
0.2*
1.0
0.5*
0.3*
± 0.4*
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Table 2.
Proliferative response of Jurkat, Ramos, and U937 cells to three alkaloids at lOOX concentrations. Each
experiment was performed in triplicate. Values are cell counts (expressed as 1.0 X 10 5 cells/mL) ± standard error.
BL=below limits of detection. The dagger <t> indicates data from Table 1 (lOOX concentration) included again here for
comparison. Asterisks (*) indicate statistically significant differences of treatment compared to control within the same
column (all p:50.003).
Cell Line
Jurkat
Control
Berberine
Chelerythrine
Sanguinarine
Berberine + Chelerythrine
Berberine + Sanguinarine
Chelerythrine + Sanguinarine
All 3 Alkaloids

30.7 ± 7.6
23.3 ± 3.5
1.3 ± 0.8*
BL*
1.3 ± 0.8*
1.0 ± O*
BL*
BL*

DISCUSSION
The aims of this experimental series were threefold: (1) to
compare the effects of berberine, chelerythrine, and sanguinarine,
alone and in all possible combinations and in various doses, on
proliferation of KS62 cells; (2) to characterize the response of
other immortalized cell lines relative to KS62 cells; and (3) to
determine if alkaloids act synergistically to influence proliferation. Findings from these experiments confirmed and extended
previous work from our lab and others.
To address aim #1, the effects of various doses of all three
alkaloids on KS62 cell proliferation was determined (Table 1 and
Figure 3). KS62 cell proliferation was negatively influenced by
sanguinarine but not berberine or chelerythrine. Sanguinarine
concentrations between O.S-2.0 µg/mL were necessary to observe
statistically significant reductions in cell proliferation, whereas
concentrations of 0.2 µg/mL or less had no effect on proliferation.
Previously, our lab demonstrated that whole-tissue extracts from
bloodroot rhizomes were able to diminish proliferation of KS62

10 7

..! 10 6
a;

....u0
...CD

.c
E
:I

z

10 5

Fig. 3.

Proliferative response of K562 cells to sanguinarine in a
dose-response test. Each experiment was performed in triplicate.
Values are cell counts (expressed as cells/mL) ± standard error.

K562t

Ramos

U937

±
±
±
±
±
±
±
±

27.0 ± 6.5
27.3 ± 4.7
s.o ± 1.3*

21.3 ± 4.9
24.7 ± 8.3
3.7 ± 2.7*
BL*
2.7 ± 1.2*
BL*
BL*
BL*

14.9
16.6
16.0
1.8
14.S
3.4
2.4
3.6

1.0
0.8
1.1
0.2*
1.0
0.S*
0.3*
0.4*

BL*
6.3 ± 0.3*
2.0 ± 1.S*
2.3 ± 1.2*
2.0 ± 0.6*

cells yet stimulate proliferation of peripheral blood mononuclear
cells obtained from healthy young human adults, and that
sanguinarine was the principal component of those extracts
(Senchina et al. 2009a). In that previous study, a cold water
extract negligibly influenced KS62 proliferation, whereas a hot
water extract reduced the cell population to 11 % of the control
value, and an ethanol extract resulted in complete cell culture
death. Sanguinarine concentrations for the three extracts once
diluted in cell culture were 0.17, 1.09, and 2.93, µg/mL,
respectively. Thus, the sanguinarine content of the hot water and
ethanol rhizome extracts used previously fall within the
0.5-2.0 µg/mL range determined in this experiment to be
necessary to see effects. The SOX dose of sanguinarine (1.0 µg/
ml) is most similar to the hot water extract used previously;
notably, the SOX dose of sanguinarine reduced the cell
population to 14% of the control value, consistent with the
effect of the hot water extract. These results suggest that, at least
in the KS62 model, sanguinarine alone may explain the antiproliferative effect seen from whole-tissue rhizome extracts.
To address aim #2, the effects of the lOOX concentrations
of all three alkaloids, alone or in various combinations, on
proliferation of Jurkat, Ramos, and U937 cells was ascertained
(Table 2). Compared to K562 cells, other immortalized cell lines
may be more susceptible to the anti-proliferative effects of
alkaloids. Once again, berberine had no effect in any of the cell
lines. Chelerythrine (1.0 µg/mL in the 100 X dose) negatively
impacted proliferation in all three cell lines (unlike in KS62
cells). Sanguinarine demonstrated an even more pronounced antiproliferative effect than in K562 cells. Sanguinarine combined
with one or more other alkaloids resulted in complete cell culture
death or cell culture stasis in both Jurkat and U937 cells; by
contrast, in Ramos cells sanguinarine showed a stronger antiproliferative effect when it was used alone, and a lesser effect
when it was combined with other alkaloids.
Why Ramos and KS62 cells are less sensitive to andJurkat and
U93 7 cells are more sensitive to the effects of sanguinarine, and
why Jurkat, Ramos, and U937 cells are more sensitive to
chelerythrine than KS62 cells is not immediately clear.
Immortalized cells are indefinitely replicating cancerous cells
derived clinically; each cell line originally started as normal
human immune cells. Hematopoetically, Jurkat and Ramos cells
(originally T and B cells, respectively) derive from the common
lymphoid progenitor whereas KS62 and U937 cells (originally
undifferentiated granulocytes and monocytes, respectively) derive
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from the common myeloid progenitor. Thus, there is nothing in
the hematopoetic lineages of these cell lines that suggests a
developmental relationship.
Berberine, chelerythrine, and sanguinarine are structurally
similar (Figure 2). Both chelerythrine and sanguinarine are
produced by bloodroot whereas berberine is not; notably, both
chelerythrine and sanguinarine demonstrated anti-proliferative
activity whereas berberine did not. Berberine was chosen as a
comparison alkaloid because it is structurally similar to bloodroot
alkaloids and produced naturally by other plant taxa, including
other members of the poppy family (lsrailov et al. 1986;
Takemura et al. 2010) as well as eight other plant families
(Philogene et al. 1984). However, berberine has shown anticancer
activity in alternative models including K562 cells (Pazhang
et al. 2011) and U937 cells (Jantova et al. 2007). Differences
between our work and others' are likely due to variances in
experimental models chosen, but it is important to note that
since berberine does not naturally occur in bloodroot, it is
perhaps not surprising to see that it behaved differently than
bloodroot alkaloids in our model.
To address aim #3, alkaloids were tested alone and in various
combinations in all four cell lines (Table 2). No synergistic
effects were apparent in our investigation in any of the examined
cell lines; however, this may be an artifact of the experimental
design and complex interplay between different alkaloids or cell
types. For example, in Jurkat and U937 cells, sanguinarine
showed such strong effects across all conditions that it possibly
"masked" or "overrode" any interplay between it and chelerythrine. By contrast, chelerythrine appeared to diminish the antiproliferative effects of sanguinarine against K562 and Ramos
cells. The difference in sanguinarine-treated wells versus wells
treated with one or more other alkaloids were not statistically
significant in either the K562 or Ramos cells at lOOX
concentrations after correcting the ex value for multiple
comparisons. Given the structural similarity between the three
alkaloids, it is possible that chelerythrine and sanguinarine bind
to the same cell surface receptors and may compete with each
other for docking sites. It is conceivable that if chelerythrine
outcompetes sanguinarine for binding sights yet has less
anticarcinogenic activity, it could diminish the effects of
sanguinarine when the two are administered simultaneously in
culture. Differences seen across the different cell lines may be
explained by differences in presence/absence, quantity, or timing
of expression of those receptors between the cell types studied
here. Further experiments are necessary to clarify interactions
between alkaloids and the exact identity of the alkaloid receptor.
The clinical utility of bloodroot alkaloids against cancer is
reaffirmed by these results, as both sanguinarine and chelerythrine demonstrated anti-proliferative activity against two or
more cell lines (and has been demonstrated previously in other
cell lines). To the best of our knowledge, this is the first report of
the effects of: berberine on J urkat and Ramos cells; chelerythrine
on K562, Ramos, and U937 cells; and sanguinarine on Jurkat,
K562, and Ramos cells. Reports elsewhere have addressed the
effects of berberine on K652 (Pazhang et al. 2011) and U937
(Jantova et al. 2007) cells, chelerythrine on Jurkat cells (Vogler
et al. 2009), and sanguinarine on U93 7 cells (Han et al. 2008).
This study has several limitations. Only limited doses were
used, and it is possible that higher or lower doses would elicit
alternate results. We examined only three alkaloids, and only two
of which were present in bloodroot; although several other
bloodroot alkaloids have been characterized (and more are likely
to be discovered), they were not readily commercially available at
the time of the study. Our study examined only immortalized

cell lines representative of the human immune system, so it is
unknown how generalizable these results are to other somatic cell
types or primary cells.
Altogether, these results suggest that benzophenanthridine
alkaloids may impact on cancer cell proliferation in a complex
manner contingent on cancer cell type, dose, and presence/
absence of other alkaloids (and possibly other phytochemicals). Of
the three alkaloids, sanguinarine demonstrated the strongest antiproliferative effect whereas berberine demonstrated none, and
chelerythrine elicited heterogeneous effects contingent on cell
type tested. While our findings should strongly encourage
medical scientists to continue their investigations of bloodroot
extracts and alkaloids in cancer models, caution is also necessary
as some adverse effects have been reported (Cienki and Zarat
2010; Childress et al. 2011; Vlachojannis et al. 2012). Thus, it is
imperative that scientists redouble their efforts at educating
medical practitioners and the lay public alike as to both the
potential clinical advantages and potential clinical adverse effects
of bloodroot extracts or constituent alkaloids.
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